David Michael Johnson's Insider Trades & SAST Disclosures
David Michael Johnson's most recent trade in Zentalis Pharmaceuticals Inc was a trade of 48,429 Common Stock done . Disclosure was reported to the exchange on June 21, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David Michael Johnson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zentalis Pharmaceuticals Inc | David Michael Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 48,429 | 192,818 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | David Michael Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 19,059 | 127,389 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | David Michael Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 24,871 | 108,330 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | David Michael Johnson | Director | Sale of securities on an exchange or to another person at price $ 66.58 per share. | 04 Oct 2021 | 7,904 | 81,059 | - | 66.6 | 526,240 | Common Stock |
| Zentalis Pharmaceuticals Inc | David Michael Johnson | Director | Sale of securities on an exchange or to another person at price $ 65.95 per share. | 04 Oct 2021 | 4,892 | 88,963 | - | 66.0 | 322,628 | Common Stock |
| Zentalis Pharmaceuticals Inc | David Michael Johnson | Director | Sale of securities on an exchange or to another person at price $ 67.20 per share. | 04 Oct 2021 | 100 | 80,959 | - | 67.2 | 6,720 | Common Stock |
| Zentalis Pharmaceuticals Inc | David Michael Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Zentalis Pharmaceuticals Inc | David Michael Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 5,000 | 93,855 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | David Michael Johnson | Director | Sale of securities on an exchange or to another person at price $ 43.50 per share. | 05 Apr 2021 | 12,897 | 88,855 | - | 43.5 | 561,021 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges